ClinicalTrials.Veeva

Menu

Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease

W

Wuhan University

Status

Enrolling

Conditions

Gastric Cancer
Hernia
Gastric Ulcer
Inflammatory Bowel Diseases
Hemorrhoids
Colorectal Cancer

Treatments

Other: No intervention will be given to patients.

Study type

Observational

Funder types

Other

Identifiers

NCT03972956
SAMPGICUS

Details and patient eligibility

About

The purposes of this study are to collect and store samples including blood, normal and tumor tissue from patients with colorectal cancer or gastric cancer, to collect and store samples including blood and/or normal gastrointestinal tissue (if available) from patients with non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD), gastric ulcer, hemorrhoids or hernia), and to create a database for the collected samples and allow access to relevant clinical information for current and future protocols.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Any patient diagnosed with colorectal cancer, gastric cancer, non-malignant disease that requires undergoing surgery.
  • Must be willing and able to provide informed consent.

Exclusion criteria

  • Subjects whose comorbidities would preclude diagnostic or therapeutic intervention.

Trial design

1,000 participants in 2 patient groups

Colorectal cancer or gastric cancer patient
Description:
Patients suffering from CRC or gastric cancer scheduled to have surgical resection of colon/rectum or stomach.
Treatment:
Other: No intervention will be given to patients.
Non-malignant disease patient
Description:
Patients suffering from non-malignant disease scheduled to have surgery.
Treatment:
Other: No intervention will be given to patients.

Trial contacts and locations

1

Loading...

Central trial contact

Tao Fu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems